title: Thrombin inhibition and coronary artery thrombolysis.
authors: Department of Internal Medicine, University of Texas Medical School, Houston.
authors: S K
authors: SK
authors: Yao
authors: J M
authors: JM
authors: McNatt
authors: H V
authors: HV
authors: Anderson
authors: J F
authors: JF
authors: Eidt
authors: K X
authors: KX
authors: Cui
authors: P
authors: P
authors: Golino
authors: P
authors: P
authors: Glas-Greenwalt
authors: J M
authors: JM
authors: Maraganore
authors: L M
authors: LM
authors: Buja
authors: J T
authors: JT
authors: Willerson
mesh_terms: D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D003328:Coronary Thrombosis / Q000097:blood / Q000188:drug therapy*; D004285:Dogs; D006493:Heparin / Q000627:therapeutic use; D024764:Hirudin Therapy; D006629:Hirudins / Q000031:analogs & derivatives; D015425:Myocardial Reperfusion; D010446:Peptide Fragments / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects; D013917:Thrombin / Q000037:antagonists & inhibitors*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
chemical_list: D006629:Hirudins; D010446:Peptide Fragments; C062510:hirugen; D006493:Heparin; D013917:Thrombin; D010959:Tissue Plasminogen Activator